Curriculum

Core Topics in Hepatology

Structured topics spanning clinical skills, core diseases, scoring systems, and transplant medicine. Each includes a clinical deep dive for when you're ready to go further.

Core Disease

Cirrhosis and Its Complications

Portal hypertension, ascites, SBP, varices, HRS, hepatic encephalopathy, and HCC surveillance — with management principles at each stage.

Read topic ~10 min
Supportive Care

Nutrition in Cirrhosis

Sarcopenia is an independent predictor of mortality and waitlist dropout. Learn why nutrition is a therapeutic intervention, not an afterthought.

Read topic ~6 min
Core Disease

Alcohol-Associated Liver Disease

From steatosis to alcohol-associated hepatitis to cirrhosis — MDF and Lille calculators, steroid dosing, MAT agents for AUD, and nutrition in severe AAH.

Read topic ~12 min
Core Disease

Autoimmune Liver Diseases

AIH, PBC, and PSC — simplified diagnostic criteria, treatment options, and cancer surveillance in PSC.

Read topic ~12 min
Core Disease

Hereditary Hemochromatosis

HFE mutations, iron overload screening, phlebotomy protocol, and why ferritin alone is insufficient — with organ-by-organ consequences of untreated iron excess.

Read topic ~10 min
Core Disease

Intestinal Failure-Associated Liver Disease

PN-induced liver disease from steatosis to cirrhosis — risk factors, lipid emulsion selection, cyclic PN, and catheter care.

Read topic ~10 min
Core Disease

Acute Liver Failure

Fulminant hepatic failure from acetaminophen overdose, viral hepatitis, Wilson disease, and beyond — King's College Criteria, NAC protocol, and transplant indications.

Read topic ~9 min
Core Disease

Hepatorenal Syndrome

Functional renal failure in advanced cirrhosis — RAAS/splanchnic vasodilation physiology, HRS-AKI vs HRS-CKD, terlipressin, and the albumin-in-SBP data that prevents it.

Read topic ~8 min
Core Disease

MASLD / MASH

The 2023 nomenclature overhaul, MetALD, FIB-4 and FibroScan for fibrosis staging, and two newly FDA-approved therapies — resmetirom and semaglutide for MASLD F2–F3.

Read topic ~10 min
Core Disease

Wilson's Disease

ATP7B mutations, the paradoxically low ALP in fulminant copper toxicity, Leipzig scoring, and why trientine has replaced D-penicillamine as first-line chelation therapy.

Read topic ~9 min
Core Disease

Vascular Liver Diseases

Budd-Chiari syndrome and portal vein thrombosis — thrombophilia workup, stepwise management from anticoagulation through TIPS, and the tumor thrombus vs. bland thrombus distinction in HCC.

Read topic ~10 min

No topics match your search or filter.